A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin

Clinical trial NCT02569814 · COMPLETED

Trial details

NCT number: NCT02569814
Sponsor: Boryung Pharmaceutical Co., Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hypertension Hyperlipidemia

Start date: 2015-09-01
Primary completion: 2015-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.